NCT07199374 PARCA (a Digital Tool) to Improve Justice and Health
| NCT ID | NCT07199374 |
| Status | Recruiting |
| Phase | — |
| Sponsor | George Mason University |
| Condition | Behavioral Addiction |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-03-01 |
| Primary Completion | 2027-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-03-01 with a primary completion date of 2027-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to assess the effectiveness of the Probation/Parole and Reentry Coach Application (PARCA)-a mobile application that allows justice-involved people to set and manage personal goals to support sustained, successful community supervision. Through this study, we aim to conduct surveys and interviews aimed to gain a better understanding of ways to improve the substance use treatment process, connections between clients and officers, and goal selection and achievement for clients using the PARCA app
Eligibility Criteria
Inclusion Criteria: All officers that supervise individuals All individuals on supervision that indicate drug use - Exclusion Criteria: Individuals that have poor performance on their job clients have serious mental health disorders \-
Contact & Investigator
Faye S. Taxman, PhD
PRINCIPAL INVESTIGATOR
George Mason University
Frequently Asked Questions
Who can join the NCT07199374 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Behavioral Addiction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07199374 currently recruiting?
Yes, NCT07199374 is actively recruiting participants. Contact the research team at ftaxman@gmu.edu for enrollment information.
Where is the NCT07199374 trial being conducted?
This trial is being conducted at Austin, United States, Dallas, United States.
Who is sponsoring the NCT07199374 clinical trial?
NCT07199374 is sponsored by George Mason University. The principal investigator is Faye S. Taxman, PhD at George Mason University. The trial plans to enroll 50 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.